Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cannabis Bioscience International Holdings Inc CBIH

Technology Scientific & Technical Instruments
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company also operates a learning platform that provides knowledge and promotes professionalism in the cannabis industry through education and research about the medical properties and healing values of the plant. Through its Alpha Research Business, based in... see more

Recent & Breaking News (OTCPK:CBIH)

Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm

Newsfile February 20, 2024

A Letter From Cannabis Bioscience International Holdings CEO Dante Picazo Regarding Actual Progress and Plans for 2024

Newsfile December 18, 2023

Texas Has Given Birth to Its First and Only Global Publicly Traded Cannabis Company, Cannabis Bioscience International Holdings

Newsfile December 15, 2023

Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement

GlobeNewswire December 6, 2023

Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website

GlobeNewswire September 11, 2023

FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH

GlobeNewswire August 21, 2023

CBIH Announces the Completion of the "Phase of Research and Discovery" for Its Phytotherapy Cancer Scientific Project

GlobeNewswire May 1, 2023

CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings

GlobeNewswire April 24, 2023

Cannabis Bioscience International Holdings Announces the Appointment of Former Dallas Cowboy David Irving as Spokesperson of Our Company

GlobeNewswire April 17, 2023

CHNC Completes Review of Its First Three Fiscal Quarters

GlobeNewswire July 12, 2022

CHNC Announces Return of Half a Billion Shares

GlobeNewswire March 28, 2022

CHNC Announces Completion of Audited Financial Statements

GlobeNewswire March 23, 2022

CHNC - Alpha Research Institute Update

GlobeNewswire November 29, 2021

CHNC Continues to Position Itself as Colombia's Quintessential Medical Cannabis Educator

GlobeNewswire November 22, 2021

CHNC Announces New Relationship with a Houston, Texas-based Professional PCAOB Accounting Firm

GlobeNewswire November 17, 2021

CHNC Seeks To Continue To Bring Medical Cannabis Education To The Middle East With New Brand Ambassador

GlobeNewswire November 5, 2021

CHNC Ventures Into Latin American Country for Extension of Its Clinical Research Facilities

GlobeNewswire October 25, 2021

CHNC Announces a New Member of Its Board of Directors

GlobeNewswire October 20, 2021

CHNC Endeavors in Artificial Intelligence Systems for Its Educational Content

GlobeNewswire October 18, 2021

CHNC to Seek Up to $3 Million Funding for Expansion of Existing Product Lines and Development of New Cannabis-Derived Therapeutics

GlobeNewswire October 1, 2021